Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03337724
Brief Title: A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer (IPATunity130)

First Submitted : November 7, 2017
First Submitted that Met QC Criteria : November 7, 2017
First Posted : November 9, 2017

Last Update Submitted that Met QC Criteria : June 8, 2021
Last Update Posted : June 9, 2021